Globus Medical Inc (GMED) Annual Income Statement

Annual · GAAP · USD millions
Access GMED quarterly income statements →
By examining income statement figures across successive periods, users can identify shifts in Globus Medical Inc's profitability and expense structure.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
2025
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Revenues
Total Revenue2,938.93
Costs & Expenses
Cost of Goods and Services Sold957.80
Gross Profit1,981.13
Selling, Administration, Marketing1,178.50
Depreciation & Amortization118.19
Research and Development Expense147.25
Business Combination, Acquisition Related Costs42.33
Other Operating Expense / -Income0.00
Litigation Settlement, Expense0.00
Total operating costs including COS2,459.12
Operating income / -loss479.82
Interest Expense7.14
Net Interest (-)Expense / Income7.14
Foreign Currency Transaction Gain (Loss), before Tax3.01
Business Combination, Bargain Purchase, Gain Recognized, Amount-117.70
Other loss / -income-17.70
Total costs & expenses2,333.86
Income & Taxes
Income / -loss before income taxes605.07
Income taxes expenses / -benefit67.20
Income after income taxes537.87
Net income / -loss of other equity0.00
Income / -loss from continuing operations537.87
Net income / -loss537.87
Income / -loss to shareholder537.87
EBIT597.93
EBITD874.77
EBITDA874.77
Earnings Per Share
Basic EPS (excl. extra items)3.98
Basic Net EPS3.98
Basic shares outstanding (Mill. of Units)135.22
Diluted Net EPS3.92
Diluted average shares (Mill. of Units)137.06
4 historic quarters locked

Sign in to unlock the full Globus Medical Inc income statement history.

About Globus Medical Inc Annual Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-K filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-K filings
  • Filed with the SEC: February 24, 2026
  • Original filing: gmed-20251231.htm

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.